Phosphagenics licenses antibody product to Agila

Bangalore: Australian drug delivery technology company Phosphagenics has licensed an injectable antibiotic product, har...

October 30, 2012 | Tuesday | News
Bionomics: Our kidney cancer trial shows clinical benefit

Singapore: Bionomics presented an update on its renal cancer candidate's (BNC105) clinical trial program at the annual A...

June 6, 2013 | Thursday | News
Osprey to capitalize on CINCOR system

Contrast induced nephropathy (CIN) is a form of kidney damage caused by the toxic effects of dyes (contrast) used by car...

July 4, 2012 | Wednesday | Influencers
Prana provides updates on clinical trials of PBT2

Singapore: Prana Biotechnology, listed with the ASX, has reported progress in the phase II clinical trials with its lead...

August 24, 2012 | Friday | News
Australian scientists find gene affecting male fertility

Singapore: A team of cancer scientists from The University of Western Australia (UWA) have found that the gene known to ...

August 19, 2013 | Monday | News
Changes in US patent law to impact global biotech

Singapore: The US has been making several modifications to its patent laws lately and this is impacting the global biote...

October 7, 2012 | Sunday | News
iSonea asthma monitor AirSonea gets CE mark

Singapore: Australia-based medical technology company iSonea has completed testing and technical documentation for the A...

September 5, 2013 | Thursday | News
Bionomics gives update about BNC105 trials

Singapore: Australia-based Bionomics' CEO, Dr Deborah Rathjen, has provided an update about the company at the Biotech...

January 9, 2013 | Wednesday | News
Michael Culme-Seymour is Marken's new APAC VP

‎Singapore: Supply chain firm, Marken has appointed Mr Michael Culme-Seymour as VP, Asia Pacific, effective Octobe...

October 4, 2013 | Friday | Influencers
Australian firm MiReven signs deal with Silence Theraeutics

Singapore: Silence Therapeutics, a leading RNA interference (RNAi) therapeutics company based in the UK, has signed an a...

August 23, 2012 | Thursday | News
Allied Herpes vaccine progresses to phase I

Singapore: Allied Healthcare has announced that its Herpes Simplex Virus (HSV-2) vaccine has received ethical approval t...

June 20, 2013 | Thursday | News
Aus, US universities give birth to cancer company

Singapore: UniQuest has partnered with US-based Emory University to package biotech assets for a new start-up company fr...

December 17, 2012 | Monday | News
Burnet director takes up key international vaccine position

Singapore: The director and CEO of Australia's largest virology and communicable disease research center, Burnet Institu...

September 14, 2012 | Friday | News
Aus vaccine firm helps US army fight bio-terrorism

Singapore: Australian infectious disease therapy and vaccine development company BioDiem's novel antimicrobial (BDM-I) w...

February 15, 2013 | Friday | News
Martin Cross is new chair of Medicines Australia

Singapore: The Board of Medicines Australia has announced that Dr Martin Cross has been appointed as the new chair of Me...

June 26, 2013 | Wednesday | News
Australia to grow Chinese anti-cancer fruit

Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...

December 13, 2012 | Thursday | News
Drug to help cancer children down under

Singapore: Two months after Leicestershire company Nova Laboratories received US approval to sell Xaluprine in the count...

July 22, 2014 | Tuesday | Regulatory
Fisher&Paykel appoints Atcor's chairman as its director

Singapore: Fisher & Paykel Healthcare has appointed Mr Donal O'Dwyer as an additional non-executive director of the...

October 30, 2012 | Tuesday | News